Wei Tang

机构：Agency for Science, Technology and Research, Hubei University of Medicine, National Institutes of Health, Sun Yat-sen University, Chinese Academy of Sciences, Fudan University, Singapore Immunology Network, National Center for Global Health and Medicine, Institut Pasteur of Shanghai, University of Tokyo Hospital, The First Affiliated Hospital, Sun Yat-sen University, National Cancer Institute, Center for Cancer Research, Huashan Hospital, Anshan Hospital · ORCID：0000-0002-7089-4391

发表论文 224 篇 · 总被引 7210 次 · h-index 42

代表论文

• Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants (2023 · Nature Genetics · 被引 156)
• SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer (2023 · Cell Reports · 被引 38)
• NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis (2025 · Nature Communications · 被引 13)
• Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry (2024 · Nature Communications · 被引 13)
• The transcription complex p52–ETS1 is essential for germinal center formation (2025 · Nature Immunology · 被引 5)
• Whole‐exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways (2024 · The Prostate · 被引 4)